Hot Stocks in Action: Precision Drilling Corporation (NYSE:PDS), CTI BioPharma Corp. (NASDAQ:CTIC), Huntsman Corporation (NYSE:HUN)

Precision Drilling Corporation (NYSE:PDS) released that it's third quarter earnings of CAD$0.18 a share, in-line with the Capital IQ Consensus of CAD$0.18. The firm revenues surged 19.7% year/year to CAD$584.6 mln vs the CAD$590.58 mln consensus, mainly due to higher pricing and drilling activity in the U.S., Canada and internationally. Precision Drilling Corporation (NYSE:PDS) stock has highest price of $8.87 in last session, beginning with a price of $8.86 and reported a lose of -8.36% to the closed at $8.11 with a day range of $7.98-$8.87. The stock is going forward its 52-week low with 2.14% and moving down from its 52 week high price with -44.37%.CTI BioPharma Corp. (NASDAQ:CTIC) reported that it has purchased worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics, through which CTI before held a sublicense with respect to tosedostat in North, Central and South America. CTI BioPharma Corp. (NASDAQ:CTIC) stock hit highest price at $2.42, beginning with a price of $2.42 and reported an increase of 0.42% to the closed at $2.41 with a day range of $2.35-$2.42. The total market capitalization remained 348.1 Million, total volume of 518015 shares held in the session was surprisingly higher than its average volume of 1086.37 shares.Huntsman Corporation (NYSE:HUN) released that its third quarter adjustment earnings of $0.60 per share, $0.07 improved than the Capital IQ Consensus anticipates of $0.53; revenues rose 1.5% year/year to $2.88B as compared to the $2.91B consensus. Shares of Huntsman Corporation (NYSE:HUN) traded at $23.10 by moving down -5.71% with price volatility of 3.95% for a week and 3.91% for a month. Its beta stands at 2.30 times.